Chronic Leukemia — Trials

Chronic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

1,705 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 207
Ph III recruiting: 22
Growth YoY: −13.3%
Industry share: 28%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 32.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (302)

clinicaltrialsPublishedShowing 1,701–1,705 of 1,705 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00462189	Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease	unknown	Phase 1	40	Cambridge Antibody TechnologyOTHER	3	Apr 18, 2007	clinicaltrials
NCT00058656	Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients	completed	Phase 1 / Phase 2	18	Xcyte TherapiesINDUSTRY	1	Nov 22, 2006	clinicaltrials
NCT00336206